351 related articles for article (PubMed ID: 19121297)
1. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
[TBL] [Abstract][Full Text] [Related]
3. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
4. Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles.
Barschak AG; Marchesan C; Sitta A; Deon M; Giugliani R; Wajner M; Vargas CR
Clin Biochem; 2008 Mar; 41(4-5):317-24. PubMed ID: 18088602
[TBL] [Abstract][Full Text] [Related]
5. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
[TBL] [Abstract][Full Text] [Related]
6. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
Snyderman SE; Goldstein F; Sansaricq C; Norton PM
Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
[TBL] [Abstract][Full Text] [Related]
8. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
9. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
[TBL] [Abstract][Full Text] [Related]
10. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
11. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
[TBL] [Abstract][Full Text] [Related]
12. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.
Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS
J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
14. Interactions among the branched-chain amino acids and their effects on methionine utilization in growing pigs: effects on plasma amino- and keto-acid concentrations and branched-chain keto-acid dehydrogenase activity.
Langer S; Scislowski PW; Brown DS; Dewey P; Fuller MF
Br J Nutr; 2000 Jan; 83(1):49-58. PubMed ID: 10703464
[TBL] [Abstract][Full Text] [Related]
15. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
16. Maple syrup urine disease in Thai infants.
Pangkanon S; Charoensiriwatana W; Sangtawesin V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
Liao CL; Herman MM; Bensch KG
Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
[TBL] [Abstract][Full Text] [Related]
18. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
Dennis JA; Healy PJ
Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and metabolic interrelationships among branched-chain keto and amino acids in humans.
Schauder P
J Lab Clin Med; 1985 Dec; 106(6):701-7. PubMed ID: 4067381
[TBL] [Abstract][Full Text] [Related]
20. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
